Health Outcomes in Rheumatoid Arthritis

Rheumatoid Arthritis Clinical Trial

— HORA  

Official title:

Health Outcomes in Rheumatoid Arthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00346411
• Other study ID #: NA_00001359
• Status: Completed
• Phase: N/A
• First received: June 28, 2006
• Last updated: October 3, 2017
• Start date: September 1, 2005
• Est. completion date: December 12, 2011

Study information

• Verified date: October 2017
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 164
• Est. completion date: December 12, 2011
• Est. primary completion date: December 12, 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Males and females age 19 or older

• Current active, adult-onset rheumatoid arthritis who meet American College of Rheumatology (ACR) criteria for RA and have: (ACR functional class I-III), defined as:

• 3 or more swollen or tender joints and

• Morning stiffness of 45min or longer

• OR judged by their rheumatologist to have active disease

• No evidence of other inflammatory diseases (e.g., Crohn's, IBS)

• Functional class I, II or III

Exclusion Criteria:

• Individuals with significant cardiovascular disease (CHF, stroke, MI)

• Unwilling to have medications monitored and/or comply with protocol

• Not fluent in English

• Planning to move from area within next year or change health insurance (which would preclude ongoing care by a Johns Hopkins rheumatologist)

• Enrolled in study evaluating efficacy of new or existing RA medications

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Locations

Country	Name	City	State
United States	Johns Hopkins Bayview Campus	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
Johns Hopkins University

Country where clinical trial is conducted

United States,